'New Warning Added To Label For Horizon Pharma's Tepezza - A Drug Important To $AMGN's Deal For The Company. ' - Tweet
Portfolio Pulse from Happy Mohamed
The FDA has added a new warning to the label for Horizon Pharma's drug Tepezza. This drug is significant to Amgen's deal for the company.
July 20, 2023 | 5:47 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
The new warning on Tepezza's label could potentially affect Amgen's deal with Horizon Pharma.
The new warning on Tepezza's label could potentially affect the terms of Amgen's deal with Horizon Pharma, or even the deal itself. This could lead to a negative impact on Amgen's stock in the short term.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
The new warning on Tepezza's label could potentially affect Horizon Pharma's deal with Amgen.
The new warning on Tepezza's label could potentially affect the terms of Horizon Pharma's deal with Amgen, or even the deal itself. This could lead to a negative impact on Horizon Pharma's stock in the short term.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80